BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

CITIGROUP INC's Holding History (CIK: 0000831001)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,244,000 Value ($000) $1,158 Avg Close — Range —
Q1 2025
Shares 3,545,000 Value ($000) $3,178 Avg Close — Range —
Q1 2024
Shares 1,234,000 Value ($000) $1,011 Avg Close — Range —
Q4 2023
Shares 3,500,000 Value ($000) $2,964 Avg Close — Range —
Q3 2023
Shares 4,240,000 Value ($000) $3,159 Avg Close — Range —
Q2 2023
Shares 2,240,000 Value ($000) $1,375 Avg Close — Range —
Q1 2023
Shares 2,040,000 Value ($000) $1,300 Avg Close — Range —
Q4 2022
Shares 1,962,000 Value ($000) $730 Avg Close — Range —
Q3 2022
Shares 1,962,000 Value ($000) $851 Avg Close — Range —
Q2 2022
Shares 836,000 Value ($000) $342 Avg Close — Range —
Q1 2022
Shares 836,000 Value ($000) $387 Avg Close — Range —